GACM
HZNP

Green Arrow Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Green Arrow Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-70,000
Closed -$860K – 190
2014
Q3 		$860K Buy
+70,000
New +$813K 0.07% 149

Other funds holding HZNP

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Green Arrow Capital Management's HZNP Position: Q4 2014 in Review

Green Arrow Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2014, closing a stake of 70,000 shares — an estimated $860K sold.

Green Arrow Capital Management first reported a position in HZNP in Q3 2014 and held it in 1 quarter. The position peaked at $860K in Q3 2014. 136 funds tracked by Wall St. Rank hold HZNP as of Q4 2014.

  • Green Arrow Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 70,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2014, an estimated $860K.
  • Green Arrow Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 1 quarter.
  • Green Arrow Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $860K in Q3 2014.
  • 136 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2014.

Based on Green Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.